105 related articles for article (PubMed ID: 22381391)
1. What is the right dose of lacosamide in pediatric patients with intractable epilepsy?
Vishwanath VA; Miller LM
Epilepsy Behav; 2012 Mar; 23(3):396-7. PubMed ID: 22381391
[No Abstract] [Full Text] [Related]
2. Lacosamide use in refractory idiopathic primary generalized epilepsy.
Zangaladze A; Skidmore C
Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide in patients with pharmacoresistant epilepsy.
Verrotti A; Loiacono G; Olivieri C; Zulli E; Zaccara G
Expert Opin Pharmacother; 2012 Oct; 13(14):2065-72. PubMed ID: 22873760
[TBL] [Abstract][Full Text] [Related]
4. [Lacosamide--oral administration (Vimpat) ].
Duh D; Peeters S
J Pharm Belg; 2011 Mar; (1):25-6. PubMed ID: 21473129
[No Abstract] [Full Text] [Related]
5. [Lacosamide, new antiepileptic with broad perspectives].
Gutiérrez-Álvarez AM; Sagarra-Mur D; Jiménez-Corral C
Neurologia; 2011 Nov; 26(9):568-9. PubMed ID: 21565431
[No Abstract] [Full Text] [Related]
6. Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine.
Belcastro V; Arnaboldi M; Taborelli A; Prontera P
Epilepsy Behav; 2011 Mar; 20(3):589-90. PubMed ID: 21367668
[No Abstract] [Full Text] [Related]
7. Initial post marketing experience with lacosamide in adult patients with epilepsy.
Harden CL; Cohn A; Lowe M; Serrano E
Epilepsy Res; 2012 Feb; 98(2-3):260-3. PubMed ID: 22015002
[TBL] [Abstract][Full Text] [Related]
8. A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy.
Greenaway C; Ratnaraj N; Sander JW; Patsalos PN
Ther Drug Monit; 2010 Aug; 32(4):448-52. PubMed ID: 20386357
[TBL] [Abstract][Full Text] [Related]
9. Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany.
Wehner T; Bauer S; Hamer HM; Hattemer K; Immisch I; Knake S; Nowak M; Reif PS; Strzelczyk A; Rosenow F
Epilepsy Behav; 2009 Nov; 16(3):423-5. PubMed ID: 19767242
[TBL] [Abstract][Full Text] [Related]
10. Experience with lacosamide in a series of children with drug-resistant focal epilepsy.
Guilhoto LM; Loddenkemper T; Gooty VD; Rotenberg A; Takeoka M; Duffy FH; Coulter D; Urion D; Bourgeois BF; Kothare SV
Pediatr Neurol; 2011 Jun; 44(6):414-9. PubMed ID: 21555051
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide-induced rash.
Koubeissi MZ; Vismer M; Ehrlich A
Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
[TBL] [Abstract][Full Text] [Related]
13. Add-on lacosamide: a retrospective study on the relationship between serum concentration, dosage, and adverse events.
Hillenbrand B; Wisniewski I; Jürges U; Steinhoff BJ
Epilepsy Behav; 2011 Nov; 22(3):548-51. PubMed ID: 21962950
[TBL] [Abstract][Full Text] [Related]
14. Lacosamide, a newer antiepileptic.
Patyar S; Medhi B
Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic drug monitoring of lacosamide].
Bentué-Ferrer D; Tribut O; Verdier MC
Therapie; 2012; 67(2):151-5. PubMed ID: 22850102
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
17. A case of refractary epilepsy and related pain due to dysmenorrhea solved with loading dose of lacosamide: clinical and neurophysiological correlates.
Marchitto N; Ceratti U; Dalmaso S; Raimondi G
Acta Biomed; 2017 Oct; 88(3):334-336. PubMed ID: 29083341
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy.
Gavatha M; Ioannou I; Papavasiliou AS
Epilepsy Behav; 2011 Apr; 20(4):691-3. PubMed ID: 21406334
[TBL] [Abstract][Full Text] [Related]
19. Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA.
Villanueva V; López-Gomáriz E; López-Trigo J; Palau J; García M; Villarroya T; Bonet M; Santafé C
Epilepsy Behav; 2012 Mar; 23(3):298-304. PubMed ID: 22370116
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
